AstraZeneca’s Soliris given EU CHMP recommendation for marketing authorisation

26th June 2023 Uncategorised 0

The authorisation would include certain patients with refractory generalised myasthenia gravis

More: AstraZeneca’s Soliris given EU CHMP recommendation for marketing authorisation
Source: News